Research Analysts Set Expectations for TSE:MDP Q4 Earnings
Medexus Pharmaceuticals Inc. (TSE:MDP – Free Report) – Equities research analysts at Raymond James lowered their Q4 2026 EPS estimates for Medexus Pharmaceuticals in a report released on Thursday, February 6th. Raymond James analyst M. Freeman now expects that the company will post earnings of $0.06 per share for the quarter, down from their prior […]
![Research Analysts Set Expectations for TSE:MDP Q4 Earnings](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/medexus-pharmaceuticals-inc-logo-1200x675.png?v=20230629055817&w=240&h=240&zc=2)